All articles by GlobalData Healthcare

What will health and social care look like under Andy Burnham?

On Monday 20 July 2026, Andy Burnham officially became the new UK Prime Minister, and the subsequent days have been…
European drug manufacturers under threat from proposed US supply chain bill

Plans to investigate US reliance on overseas pharmaceutical manufacturing and supply chains are set to reveal the country’s reliance on…
Cell and gene therapy manufacturers turn to specialist automation partners

Cell and gene therapy manufacturers are partnering with specialist technology companies to address the challenges associated with scaling complex therapies.…
Australia approves first-in-class Niktimvo for later-line cGVHD

On 1 May 2026, Specialised Therapeutics’ Niktimvo (axatilimab) was registered in the Australian Register of Therapeutic Goods following priority review…
FDA regenerative medicine approvals show growing momentum

Following several years of limited activity, FDA approvals for regenerative medicines have accelerated, culminating in a record eight approvals in…

Dimerix acquisition of DMX-652 bolsters kidney disease development

Dimerix, a clinical-stage biopharmaceutical company developing kidney disease treatments, recently announced that it had acquired DMX-652 from Mission Therapeutics. The…
Adult epilepsy market to reach $17.bn across 7MM by 2035

The adult epilepsy market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan)…
Speciality versus diversity: the four-way CDMO race in outsourced HPAPI manufacturing

Known for their low-dose therapeutic efficacy and high target affinity, HPAPIs are in high demand by biopharma companies, which often…
Outsourcing gap widens: Europe pulls away from US in new drug manufacturing

In 2025, the dose outsourcing gap between the proportion of newly approved biosimilar and innovator products outsourced to European and…
EAN 2026: Bocunebart’s promise as migraine preventive in treatment-refractory patients

On 29 June, at the 12th Congress of the European Academy of Neurology (EAN) 2026, as part of a late-breaking…